Company / Return on Equity (ROE)
Genprex, Inc. Return on Equity (ROE) History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-416.1%
FY2024
5-year range
-773.3% / -50.1%
FY2020-FY2024
Trend
-290.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Genprex, Inc. reports negative total equity of -416.1% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-416.1% in FY2024 with a 3-year CAGR of -358.1%.
Declined from -50.1% to -416.1% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -358.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on equity (roe) decreased 290.4% year-over-year.
- Peak return on equity (roe) was recorded in FY2022.
- Lowest return on equity (roe) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -24.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -416.1% | -290.4% |
| FY2023 | -106.6% | -112.9% |
| FY2022 | -50.1% | +13.7% |
| FY2021 | -58.0% | +92.5% |
| FY2018 | -773.3% | -204.1% |
| FY2017 | -254.3% | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026